The Role of Nurses as Guides in Inflammatory Bowel Diseases
Review Article
DOI:
https://doi.org/10.5281/zenodo.15031216Keywords:
Bowel Diseases, Inflammatory, Crohn's Disease, Ulcerative Colitis, Internal Medicine Nursing, Patient EducationAbstract
Inflammatory Bowel Diseases are a group of chronic and recurrent inflammatory disorders affecting the gastrointestinal system, with unknown etiology. Crohn's Disease and Ulcerative Colitis are the most common subtypes, associated with physical symptoms and psychosocial issues that negatively impact the quality of life. The management of Inflammatory Bowel Diseases requires a multidisciplinary approach, and the guiding role of nurses is critical for symptom management, treatment adherence, and enhancing patients' quality of life.
Nurses actively participate in symptom management, nutritional counseling, psychosocial support, and patient education, creating individualized care plans tailored to patients' needs. Specifically, nutritional management, psychosocial support, and educational strategies help alleviate symptoms and improve treatment adherence. Additionally, the utilization of health technologies, such as mobile health applications and tele-health services, facilitates patient follow-up and enhances treatment processes.
Psychosocial support services assist patients in managing stress, depression, and anxiety, thereby positively impacting their quality of life. Moreover, support groups and counseling services reduce social isolation and strengthen psychological resilience. Nurses play a crucial role in patient education and raising public awareness, which helps reduce social stigma and improves patients' compliance with treatment.
This review highlights the importance of nursing guidance in the management of Inflammatory Bowel Diseases and provides a guiding perspective for future research. Multidisciplinary teamwork, individualized care plans, and the integration of digital health applications are effective strategies for improving the quality of life of Inflammatory Bowel Diseases patients. In this context, strengthening the educational and counseling roles of nurses is essential for effective Inflammatory Bowel Diseases management.
References
Forbes A, Escher J, Hebuterne XH, et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36(2):321–347. doi:10.1016/j.clnu.2016.12.027.
Crohn’s and Colitis Foundation of America (CCFA). The Facts About Inflammatory Bowel Diseases. Crohn’s and Colitis Foundation of America; 2020. Accessed February 28, 2025. https://www.crohnscolitisfoundation.org/.
Akdemir N, Tosun N. Barsak hastalıkları ve hemşirelik bakımı. In: Akdemir N, Birol L, eds. İç Hastalıkları ve Hemşirelik Bakımı. 5th ed. Akademisyen Kitabevi; 2020:834–838.
Schmelzer M. Nursing management: Lower gastrointestinal problems. In: Williams LS, Hopper PD, eds. Understanding Medical-Surgical Nursing. F.A. Davis Company; 2015:981–982.
Dharni K, Singh A, Sharma S, et al. Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990–2019). Indian J Gastroenterol. 2024; 43:188–198. doi:10.1007/s12664-023-01430-z.
Dağlı Ü. İnflamatuvar bağırsak hastalıklarının epidemiyolojisi ve risk faktörleri. In: Dağlı Ü, ed. Bağırsak Hastalıkları. Türk Gastroenteroloji Vakfı; 2008:15–20.
Tozun N, Atug O, Imeryuz N, et al. Clinical characteristics of inflammatory bowel disease in Turkey: A multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43(1):51–57. doi:10.1097/MCG.0b013e3181574636.
Buran T. İnflamatuar barsak hastalığında epidemiyoloji, prevalans ve insidans. Turkiye Klinikleri Gastroenterohepatoloji - Özel Konular. 2017;10(1):15–17.
Akyüz F, Agargün BF, Atug O, et al. Epidemiological characteristics of inflammatory bowel diseases in the last decade: Multi-center Türkiye data. J Crohns Colitis. 2024;18(Supplement_1):i2025–i2027. doi:10.1093/ecco-jcc/jjad212.1261.
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389(10080):1741–1755. doi:10.1016/S0140-6736(16)31711-1.
Wu T, Cheng H, Zhuang J, Liu X, Ouyang Z, Qian R. Risk factors for inflammatory bowel disease: An umbrella review. Front Cell Infect Microbiol. 2025;14:1410506. doi:10.3389/fcimb.2024.1410506.
Kaplan GG. The global burden of IBD: From 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi:10.1038/nrgastro.2015.150.
Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119–124. doi:10.1038/nature11582.
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0.
Sudhakar P, Wellens J, Verstockt B, Ferrante M, Sabino J, Vermeire S. Holistic healthcare in inflammatory bowel disease: Time for patient-centric approaches? Gut. 2023;72(1):192–204. doi:10.1136/gutjnl-2022-328221.
Yan J, Wang L, Gu Y, Hou H, Liu T, Ding Y, Cao H. Dietary patterns and gut microbiota changes in inflammatory bowel disease: Current insights and future challenges. Nutrients. 2022;14(19):4003. doi:10.3390/nu14194003.
Özgürsoy Uran B. Güncel Kılavuz Önerileriyle İnflamatuar Barsak Hastalıklarında Semptom Yönetimi. Uludag Med J. 2020;46(1):101–111. doi:10.32708/uutfd.657842.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Medica Ruha
This work is licensed under a Creative Commons Attribution 4.0 International License.
